Survival of patients following secondary cytoreductive surgery in ovarian cancer.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002277:Carcinoma / Q000401:mortality* / Q000601:surgery / Q000628:therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008722:Methods; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000401:mortality* / Q000601:surgery / Q000628:therapy; D011379:Prognosis; D012189:Retrospective Studies
D000970:Antineoplastic Agents